Impact of the COVID-19 Pandemic on Healthcare Resource Utilization in Individuals with Major Depressive Disorder.

Liberman, Joshua N; Bhattacharjee, Sandipan; Rui, Pinyao; Ruetsch, Charles; Rothman, Brian; Kulkarni, Amit; Forma, Felicia

Liberman, Joshua N; Bhattacharjee, Sandipan; Rui, Pinyao; Ruetsch, Charles; Rothman, Brian; Kulkarni, Amit; Forma, Felicia.

Afiliación

Liberman JN; Health Analytics, LLC, USA.
Bhattacharjee S; Otsuka Pharmaceutical Development & Commercialization, Inc, USA.
Rui P; Health Analytics, LLC, USA.
Ruetsch C; Health Analytics, LLC, USA.
Rothman B; Otsuka Pharmaceutical Development & Commercialization, Inc, USA.
Kulkarni A; Otsuka Pharmaceutical Development & Commercialization, Inc, USA.
Forma F; Former employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Health Serv Res Manag Epidemiol ; 9: 23333928221111864, 2022.

Article en En | MEDLINE | ID: mdl-35832488

Palabras clave

COVID-19; access to care; major depressive disorder; medications; primary care; telehealth

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies Aspecto: Implementation_research Idioma: En Revista: Health Serv Res Manag Epidemiol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google